Literature DB >> 4266671

Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma.

D P Sengar, G Opelz, P I Terasaki.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4266671

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

1.  In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  Lymphocytotoxins and mixed leucocyte culture blocking factor activity in the plasma of uraemic patients undergoing haemodialysis.

Authors:  D P Sengar; A Rashid; L Perelmutter; J E Harris
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

3.  The correlation between humoral antibodies and rejection after renal transplantation.

Authors:  H Yoshioka; R T McCalmon
Journal:  Jpn J Surg       Date:  1979-06

4.  Editorial: Component transfusion therapy.

Authors: 
Journal:  Br Med J       Date:  1974-08-31

5.  Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.

Authors:  N Suciu-Foca; J A Buda; T Thiem; K Reemtsma
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

6.  Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions.

Authors:  C Russo; V Quaranta; F Indiveri; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

7.  Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.

Authors:  A Rashid; D P Sengar; J E Harris
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

8.  Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.